# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001493152-22-030999
Filing Date
2022-11-08
Accepted
2022-11-08 17:25:39
Documents
7
Period of Report
2022-11-08

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | formdef14a.htm | DEF 14A | 746768
2 |  | def14a_001.jpg | GRAPHIC | 2506
3 |  | def14a_002.jpg | GRAPHIC | 2568
4 |  | def14a_003.jpg | GRAPHIC | 3391
5 |  | def14a_004.jpg | GRAPHIC | 3745
6 |  | def14a_005.jpg | GRAPHIC | 291288
7 |  | def14a_006.jpg | GRAPHIC | 266579
| Complete submission text file | 0001493152-22-030999.txt |  | 1533340

Mailing Address 120 PRESIDENTIAL WAY, SUITE 330 WOBURN MA 01801
Business Address 120 PRESIDENTIAL WAY, SUITE 330 WOBURN MA 01801 781-245-1325
Biofrontera Inc. (Filer) CIK: 0001858685 (see all company filings)

EIN.: 473765675 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40943 | Film No.: 221370033
SIC: 2834 Pharmaceutical Preparations